Cathie Wood buys CRISPR Therapeutics shares for two consecutive days
CRSP CRISPR Therapeutics AG
$40.37 -4.43%
View chart & analysis → - 1Cathie Wood purchased $1.1 million in shares on Friday, October 9.
- 2Cathie Wood purchased $2.3 million in shares on Monday, October 12.
- 3CRISPR Therapeutics recorded $76 million in Casgevy revenue for the second quarter.
So what's the key point?
Cathie Wood bought CRISPR Therapeutics shares over two days. CRISPR Therapeutics generated $76 million in revenue during the second quarter.
Source The Motley Fool +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.